Linnaeus Therapeutics LLC

Linnaeus Therapeutics LLC is a biotech company in Philadelphia, United States, founded in 2018. It has 3 recorded funding rounds.

Promoting resilience against cancer, cardiometabolic disease, and aging

Employees
1–10
Founded
2018
Business Model
B2G
Rounds
3

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Linnaeus Therapeutics is a clinical-stage biopharmaceutical company developing GPER-targeted medicines for cancer, cardiometabolic disease, and healthy aging. Their lead candidate, LNS8801, is a first-in-class oral GPER agonist with clinical evidence of antitumor activity and cardiometabolic benefits. The company has received multiple NCI SBIR awards totaling over $8M and is collaborating with Merck on combination trials with KEYTRUDA.

Summary

It lists 1–10 employees. Investors include Kairos Ventures and ARPA-H.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated

Sign up to see all 3 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Linnaeus Therapeutics LLC on Indexed.vc
<a href="https://indexed.vc/companies/linnaeus-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/linnaeus-therapeutics-llc" alt="Linnaeus Therapeutics LLC on Indexed.vc" width="260" height="76" /></a>